ANIP
ANI Pharmaceuticals Inc
$5.65M
Cluster sell
Discretionary Insider Activity
Date:
05/11/2026
Insiders:
Rowland Thomas Andrew, SVP, HEAD - ESTABLISHED BRANDS, and 3 others
Prior trend:
25 weeks of no clear discretionary insider activity

Summary

A $5.65M cluster sell for ANI Pharmaceuticals Inc (ANIP) on 05/11/2026 after 25 weeks of no clear discretionary insider activity trend.

Reports

Action Amount Date Insider Role(s) SEC Filing No
Sell $36K 05/13/2026 Rowland Thomas Andrew SVP, HEAD - ESTABLISHED BRANDS 0001507496-26-000012
Sell $1.13M 05/13/2026 Walsh Patrick D Director 0001720568-26-000005
Sell $4.27M 05/13/2026 Lalwani Nikhil Director, PRESIDENT & CEO 0001822629-26-000011
Sell $220K 05/13/2026 Gutwerg Ori SVP, GENERICS 0001846478-26-000013

Stake Changes

Action Insider Role(s) Total Change % Change
Sell Rowland Thomas Andrew SVP, HEAD - ESTABLISHED BRANDS $36K 1.2%
Sell Walsh Patrick D Director $1.13M 26.7%
Sell Lalwani Nikhil Director, PRESIDENT & CEO $4.27M 13.6%
Sell Gutwerg Ori SVP, GENERICS $220K 3.4%

Transactions

Action Amount Date Insider Security Type SEC Code
Sell $321K 05/11/2026 Walsh Patrick D Common Stock Discretionary Sale
Sell $4.27M 05/11/2026 Lalwani Nikhil Common Stock Discretionary Sale
Sell $36K 05/12/2026 Rowland Thomas Andrew Common Stock Discretionary Sale
Sell $220K 05/12/2026 Gutwerg Ori Common Stock Discretionary Sale
Sell $806K 05/13/2026 Walsh Patrick D Common Stock Discretionary Sale

Price Changes

Price at Scan Price at 30 Days 30 Day Change % Change Price at 1 Year 1 Year Change % Change
$80.88 $81.68 +$0.80 +0.99%

Stats

Prior max multiple:
7.4
Prior median multiple:
11.8

Metadata

Signal ID:
B5xwNogafKV737AW
Scanned on:
05/13/2026
Status:
Current